Prelude Capital Management’s DexCom DXCM Stock Holding History

Prelude Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-73,200	Closed	-$1.05M	–	1558
2017 Q4	$1.05M	Buy	73,200 +12,000	+20%	+$156K	0.08%	248
2017 Q3	$749K	Sell	61,200 -7,200	-11%	-$127K	0.07%	292
2017 Q2	$1.25M	Sell	68,400 -14,000	-17%	-$259K	0.12%	184
2017 Q1	$1.75M	Buy	82,400 +27,200	+49%	+$531K	0.17%	147
2016 Q4	$824K	Buy	+55,200	New	+$978K	0.1%	239

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Prelude Capital Management's DXCM Position: Q1 2026 in Review

Prelude Capital Management reduced its DexCom (DXCM) stake by 66% in Q1 2026, selling an estimated $753K and leaving 5,543 shares worth $348K. The position accounts for 0.03% of the portfolio, ranked #649.

Prelude Capital Management first reported a position in DXCM in Q4 2014 and has held it in 25 quarters since. The position peaked at $2.71M in Q1 2022. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Prelude Capital Management held 5,543 shares of DexCom worth $348K as of Q1 2026.
Prelude Capital Management sold 10,818 DexCom shares in Q1 2026, an estimated $753K.
DexCom made up 0.03% of Prelude Capital Management's portfolio in Q1 2026, its #649 holding.
Prelude Capital Management first reported a position in DexCom in Q4 2014 and has held it in 25 quarters since.
Prelude Capital Management's DexCom position peaked at $2.71M in Q1 2022.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.